Alkermes' Sleeping Disorder Studies' Data Look Excellent, Analyst Says
On Tuesday, Alkermes plc ALKS revealed topline results from the narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH) cohorts of a phase 1b,…
Stay updated with breaking news from Alkermes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On Tuesday, Alkermes plc ALKS revealed topline results from the narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH) cohorts of a phase 1b,…
Stocks that are trading heavily or have substantial price changes on Tuesday: BlackBerry, Alkermes rise; Neogen, Tilray Brands fall.
China Universal Asset Management Co. Ltd. boosted its position in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 352.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 19,306 shares of the company’s stock after buying an additional 15,035 shares during the quarter. China […]
Marketresearch.biz reports that the Increasing incidence of schizophrenia in developed economies, growing awareness among individuals about treatments for schizophrenia, and increasing popularity among individuals for long-acting injectable (LAI) antipsychotics are key factors driving the growth of the global schizo...